Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Mycobacterium Tuberculosis Market Grown from 2024 to 2025?

In recent times, the market size for Mycobacterium tuberculosis has seen a robust growth. The growth is projected to hike from $3.54 billion in 2024 to $3.74 billion in 2025 with a compound annual growth rate (CAGR) of 5.5%. Several factors are attributed to the growth observed in the historical period like the surge in TB cases in high-burden countries, increased financial aid from international bodies, extensive TB screening programs, a rise in TB-HIV co-infections, and an increase in international travel and migration leading to the spread of TB.

What Growth Rate Is Anticipated for the Mycobacterium Tuberculosis Market in the Coming Years?

Expectations are high for the mycobacterium tuberculosis market to experience significant growth in the upcoming years, reaching a worth of $4.57 billion in 2029, with a compound annual growth rate (CAGR) of 5.2%. The growth anticipation in the projected period can be linked to factors such as a global increase in TB prevalence and drug-resistant TB cases, heightened awareness around the transmission and prevention of TB, plus government endeavours and funding towards TB eradication. Furthermore, a surge in research and developmental activities surrounding TB treatment adds to this. There are several anticipated trends in the forecast period, including the evolution of TB diagnostic technologies, ready availability of swift TB testing methodologies, the emergence of new TB vaccinations, the creation of innovative drug protocols for multidrug-resistant TB, alongside technological advancements in TB drug formulation.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24325&type=smp

Who Are the Leading Companies in the Mycobacterium Tuberculosis Market?

Major companies operating in the mycobacterium tuberculosis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Macleods Pharmaceuticals Limited, bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Lupin Limited, Zydus Cadila Healthcare Limited, Cepheid Inc., Serum Institute of India Pvt. Ltd., Oxford Immunotec USA Inc., Panacea Biotec Limited, International AIDS Vaccine Initiative Inc., HiMedia Laboratories Private Limited, Akonni Biosystems Inc.

What Are the Key Drivers of the Mycobacterium Tuberculosis Market?

Accelerated growth in the mycobacterium tuberculosis market is expected due to increased research and development investments. The systematic investigation and experimentation involved in research and development engenders new knowledge or enhances existing products, services, or technologies. This significant increase in research and development, stimulated by advanced technology, necessitates persistent innovation to remain relevant in the continuously evolving worldwide markets. Research and development contribute to mycobacterium tuberculosis treatment by facilitating the discovery of new potential drugs that can bypass resistance to current therapies, thereby enhancing the efficacy of treatment and patient outcomes. For instance, in March 2024, as reported by the Foreign, Commonwealth, and Development Office, a government department in the UK, the UK government declared a funding increase of $5 million (£4 million) for the TB REACH program. The program is set to aid innovative strategies that enhance tuberculosis diagnosis and treatment in low to middle income countries. This funding will enable 500,000 individuals to access healthcare, diagnose 37,000 people with TB, and possibly save over 15,000 lives. Hence, the surge in research and development financial input will stimulate mycobacterium tuberculosis market growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24325&type=smp

What Are the Key Market Segments in the Mycobacterium Tuberculosis Industry?

The mycobacterium tuberculosis market covered in this report is segmented –

1) By Product Type: Instruments, Reagents And Consumables, Software Solutions

2) By Diagnostic Method: Culture-Based Methods, Molecular Diagnosis, Immunological Tests

3) By Route Of Administration: Oral, Injectable

4) By End User: Hospitals, Diagnostic Laboratories, Research Institutions

Subsegments:

1) By Instruments: Diagnostic Instruments, Detection Instruments, Molecular Diagnostic Instruments, Tuberculosis Culture Systems

2) By Reagents And Consumables: Polymerase Chain Reaction Reagents, Tuberculosis Culture Media, Antigen Kits, Test Strips, Tuberculosis Diagnostic Kits

3) By Software Solutions: Laboratory Information Management Systems (LIMS), Diagnostic Software, Data Management Software, Telemedicine Solutions for TB Diagnosis

What Are the Latest Trends in the Mycobacterium Tuberculosis Market?

Leading firms in the mycobacterium tuberculosis market are concentrating on creating innovative solutions, such as automated TB tests, to provide quicker and more precise outcomes. These automated TB tests employ advanced technology and automated systems to swiftly and correctly identify Mycobacterium tuberculosis and drug resistance while needing minimal human assistance. For instance, Revvity Inc., a biotech company based in the U.S., announced in April 2025 the FDA approval for their Auto-Pure 2400 liquid handling platform integrated with the T-SPOT TB test. This integration enhances automated TB testing as it allows for processing a larger volume without losing accuracy. The Auto-Pure 2400 platform merges liquid handling and magnetic cell isolation technology, enabling it to test up to 24 samples in a single run and finish Day 1 of testing in less than 3.5 hours with minimal user interference. The T-SPOT.TB test – the only WHO-recognized ELISPOT-based IGRA – delivers reproducible results with fewer uncertainties, lesser requirement for retesting, and dependable performance in patients with compromised immune systems.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/mycobacterium-tuberculosis-global-market-report

What Are the Key Regional Markets in the Mycobacterium Tuberculosis Industry?

North America was the largest region in the mycobacterium tuberculosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mycobacterium tuberculosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/customise?id=24325&type=smp

This Report Delivers Insight On:

1. How big is the mycobacterium tuberculosis market, and how is it changing globally?

2. Who are the major companies in the mycobacterium tuberculosis market, and how are they performing?

3. What are the key opportunities and risks in the mycobacterium tuberculosis market right now?

4. Which products or customer segments are growing the most in the mycobacterium tuberculosis market?

5. What factors are helping or slowing down the growth of the mycobacterium tuberculosis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model